BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G951. A total of 6 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,035,000 | -7.8% | 13,300 | -2.2% | 0.00% | 0.0% |
| Q1 2016 | $1,122,000 | -41.8% | 13,600 | -26.1% | 0.00% | -50.0% |
| Q4 2015 | $1,928,000 | -35.3% | 18,400 | -35.0% | 0.00% | -33.3% |
| Q3 2015 | $2,981,000 | -37.4% | 28,300 | -18.7% | 0.00% | -25.0% |
| Q2 2015 | $4,760,000 | -22.5% | 34,800 | -29.4% | 0.00% | -33.3% |
| Q1 2015 | $6,144,000 | +226.8% | 49,300 | +137.0% | 0.01% | +200.0% |
| Q4 2014 | $1,880,000 | +40.1% | 20,800 | +11.8% | 0.00% | +100.0% |
| Q3 2014 | $1,342,000 | -27.8% | 18,600 | -37.8% | 0.00% | -50.0% |
| Q2 2014 | $1,860,000 | -23.4% | 29,900 | -16.0% | 0.00% | -33.3% |
| Q1 2014 | $2,428,000 | -22.4% | 35,600 | -20.0% | 0.00% | -25.0% |
| Q4 2013 | $3,127,000 | +33.6% | 44,500 | +37.3% | 0.00% | 0.0% |
| Q3 2013 | $2,340,000 | -42.2% | 32,400 | -55.3% | 0.00% | -42.9% |
| Q2 2013 | $4,045,000 | – | 72,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 35,000 | $3,403,400 | 0.01% |
| SIMPLEX TRADING, LLC | 49,200 | $4,784 | 0.00% |
| JANE STREET GROUP, LLC | 58,200 | $5,659,368 | 0.00% |
| JPMORGAN CHASE & CO | 26,300 | $2,557,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |